Author:
Pan Chenghao,Luo Mengxin,Lu Yang,Pan Xiaohui,Chen Xi,Ding Ling,Che Jinxin,He Qiaojun,Dong Xiaowu
Funder
Natural Science Foundation of Zhejiang Province
National Natural Science Foundation of China
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New horizons in the mechanisms and therapeutic strategies for PD-L1 protein degradation in cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09
2. Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 Pathway;Journal of Medicinal Chemistry;2024-04-10
3. Recent advances and mechanisms of action of PD-L1 degraders as potential therapeutic agents;European Journal of Medicinal Chemistry;2024-03
4. Syntheses, characterizations, crystal structures and Hirshfeld surface analyses of methyl 4-[4-(difluoromethoxy)phenyl]-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, isopropyl 4-[4-(difluoromethoxy)phenyl]-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate and tert-butyl 4-[4-(difluoromethoxy)phenyl]-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate;Acta Crystallographica Section E Crystallographic Communications;2024-02-08
5. Beyond inhibition against the PD-1/PD-L1 pathway: development of PD-L1 inhibitors targeting internalization and degradation of PD-L1;RSC Medicinal Chemistry;2024